RAAS  ||| S:0 E:5 ||| NNP
inhibition  ||| S:5 E:16 ||| NN
and  ||| S:16 E:20 ||| CC
cardiorenal  ||| S:20 E:32 ||| JJ
syndrome  ||| S:32 E:41 ||| NN
The  ||| S:41 E:45 ||| DT
consensus  ||| S:45 E:55 ||| NN
conference  ||| S:55 E:66 ||| NN
on  ||| S:66 E:69 ||| IN
cardio-renal  ||| S:69 E:82 ||| JJ
syndromes  ||| S:82 E:92 ||| NNS
( ||| S:92 E:93 ||| -LRB-
2008 ||| S:93 E:97 ||| CD
)  ||| S:97 E:99 ||| -RRB-
defined  ||| S:99 E:107 ||| NN
' ||| S:107 E:108 ||| POS
cardio-renal  ||| S:108 E:121 ||| JJ
syndromes ||| S:121 E:130 ||| NN
'  ||| S:130 E:132 ||| POS
as  ||| S:132 E:135 ||| NN
' ||| S:135 E:136 ||| POS
disorders  ||| S:136 E:146 ||| NNS
of  ||| S:146 E:149 ||| IN
the  ||| S:149 E:153 ||| DT
heart  ||| S:153 E:159 ||| NN
and  ||| S:159 E:163 ||| CC
kidneys  ||| S:163 E:171 ||| NN
whereby  ||| S:171 E:179 ||| WRB
acute  ||| S:179 E:185 ||| JJ
or  ||| S:185 E:188 ||| CC
chronic  ||| S:188 E:196 ||| JJ
dysfunction  ||| S:196 E:208 ||| NN
in  ||| S:208 E:211 ||| IN
one  ||| S:211 E:215 ||| CD
organ  ||| S:215 E:221 ||| NN
may  ||| S:221 E:225 ||| MD
induce  ||| S:225 E:232 ||| VB
acute  ||| S:232 E:238 ||| JJ
or  ||| S:238 E:241 ||| CC
chronic  ||| S:241 E:249 ||| JJ
dysfunction  ||| S:249 E:261 ||| NN
of  ||| S:261 E:264 ||| IN
the  ||| S:264 E:268 ||| DT
other ||| S:268 E:273 ||| JJ
'  ||| S:273 E:275 ||| ''
and  ||| S:275 E:279 ||| CC
identified  ||| S:279 E:290 ||| VBD
five  ||| S:290 E:295 ||| CD
subtypes  ||| S:295 E:304 ||| NN
of  ||| S:304 E:307 ||| IN
the  ||| S:307 E:311 ||| DT
syndromes ||| S:311 E:320 ||| NN
.  ||| S:320 E:322 ||| .
Various  ||| S:322 E:330 ||| JJ
pathophysiologic  ||| S:330 E:347 ||| FW
mechanisms  ||| S:347 E:358 ||| FW
underlie  ||| S:358 E:367 ||| FW
cardiorenal  ||| S:367 E:379 ||| FW
syndrome  ||| S:379 E:388 ||| FW
including  ||| S:388 E:398 ||| FW
hemodynamic  ||| S:398 E:410 ||| FW
derangements ||| S:410 E:422 ||| FW
,  ||| S:422 E:424 ||| ,
reduced  ||| S:424 E:432 ||| VBD
cardiac  ||| S:432 E:440 ||| JJ
output  ||| S:440 E:447 ||| NN
leading  ||| S:447 E:455 ||| VBG
to  ||| S:455 E:458 ||| TO
impaired  ||| S:458 E:467 ||| VB
renal  ||| S:467 E:473 ||| JJ
perfusion ||| S:473 E:482 ||| NN
,  ||| S:482 E:484 ||| ,
reduced  ||| S:484 E:492 ||| VBD
stroke  ||| S:492 E:499 ||| JJ
volume ||| S:499 E:505 ||| NN
,  ||| S:505 E:507 ||| ,
raised  ||| S:507 E:514 ||| VBD
atrial  ||| S:514 E:521 ||| VBN
filling  ||| S:521 E:529 ||| VBG
pressures ||| S:529 E:538 ||| NNS
,  ||| S:538 E:540 ||| ,
elevated  ||| S:540 E:549 ||| VBD
atrial  ||| S:549 E:556 ||| JJ
pressures ||| S:556 E:565 ||| NNS
,  ||| S:565 E:567 ||| ,
sodium  ||| S:567 E:574 ||| NN
and  ||| S:574 E:578 ||| CC
water  ||| S:578 E:584 ||| NN
retention ||| S:584 E:593 ||| NN
,  ||| S:593 E:595 ||| ,
venous  ||| S:595 E:602 ||| JJ
congestion ||| S:602 E:612 ||| NN
,  ||| S:612 E:614 ||| ,
right  ||| S:614 E:620 ||| RB
ventricular  ||| S:620 E:632 ||| JJ
dysfunction  ||| S:632 E:644 ||| NN
and  ||| S:644 E:648 ||| CC
venous  ||| S:648 E:655 ||| JJ
hypertension  ||| S:655 E:668 ||| NN
causing  ||| S:668 E:676 ||| VBG
increased  ||| S:676 E:686 ||| VBN
renal  ||| S:686 E:692 ||| JJ
venous  ||| S:692 E:699 ||| JJ
pressure ||| S:699 E:707 ||| NN
,  ||| S:707 E:709 ||| ,
intra-abdominal  ||| S:709 E:725 ||| JJ
hypertension ||| S:725 E:737 ||| NN
,  ||| S:737 E:739 ||| ,
various  ||| S:739 E:747 ||| JJ
neurohormonal  ||| S:747 E:761 ||| NNS
adaptations  ||| S:761 E:773 ||| VBP
including  ||| S:773 E:783 ||| VBG
activation  ||| S:783 E:794 ||| NN
of  ||| S:794 E:797 ||| IN
the  ||| S:797 E:801 ||| DT
renin-angiotensin-aldosterone  ||| S:801 E:831 ||| JJ
system ||| S:831 E:837 ||| NN
,  ||| S:837 E:839 ||| ,
adaptive  ||| S:839 E:848 ||| JJ
activation  ||| S:848 E:859 ||| NN
of  ||| S:859 E:862 ||| IN
the  ||| S:862 E:866 ||| DT
sympathetic  ||| S:866 E:878 ||| JJ
nervous  ||| S:878 E:886 ||| JJ
system ||| S:886 E:892 ||| NN
,  ||| S:892 E:894 ||| ,
cytokine  ||| S:894 E:903 ||| JJ
release  ||| S:903 E:911 ||| NN
and  ||| S:911 E:915 ||| CC
oxidative  ||| S:915 E:925 ||| JJ
stress ||| S:925 E:931 ||| NN
.  ||| S:931 E:933 ||| .
Although  ||| S:933 E:942 ||| IN
there  ||| S:942 E:948 ||| EX
are  ||| S:948 E:952 ||| VBP
standardized  ||| S:952 E:965 ||| JJ
clinical  ||| S:965 E:974 ||| JJ
guidelines  ||| S:974 E:985 ||| NNS
for  ||| S:985 E:989 ||| IN
the  ||| S:989 E:993 ||| DT
management  ||| S:993 E:1004 ||| NN
of  ||| S:1004 E:1007 ||| IN
heart  ||| S:1007 E:1013 ||| NN
failure ||| S:1013 E:1020 ||| NN
,  ||| S:1020 E:1022 ||| ,
and  ||| S:1022 E:1026 ||| CC
chronic  ||| S:1026 E:1034 ||| JJ
kidney  ||| S:1034 E:1041 ||| NN
disease ||| S:1041 E:1048 ||| NN
,  ||| S:1048 E:1050 ||| ,
respectively ||| S:1050 E:1062 ||| RB
,  ||| S:1062 E:1064 ||| ,
there  ||| S:1064 E:1070 ||| EX
are  ||| S:1070 E:1074 ||| VBP
no  ||| S:1074 E:1077 ||| DT
similar  ||| S:1077 E:1085 ||| JJ
consensus  ||| S:1085 E:1095 ||| NN
clinical  ||| S:1095 E:1104 ||| JJ
guidelines  ||| S:1104 E:1115 ||| NNS
for  ||| S:1115 E:1119 ||| IN
the  ||| S:1119 E:1123 ||| DT
management  ||| S:1123 E:1134 ||| NN
of  ||| S:1134 E:1137 ||| IN
the  ||| S:1137 E:1141 ||| DT
cardiorenal  ||| S:1141 E:1153 ||| JJ
syndromes ||| S:1153 E:1162 ||| NN
.  ||| S:1162 E:1164 ||| .
RAAS  ||| S:1164 E:1169 ||| NNP
inhibition  ||| S:1169 E:1180 ||| NN
is  ||| S:1180 E:1183 ||| VBZ
advocated  ||| S:1183 E:1193 ||| VBN
in  ||| S:1193 E:1196 ||| IN
treating  ||| S:1196 E:1205 ||| VBG
systolic  ||| S:1205 E:1214 ||| JJ
heart  ||| S:1214 E:1220 ||| NN
failure ||| S:1220 E:1227 ||| NN
.  ||| S:1227 E:1229 ||| .
There  ||| S:1229 E:1235 ||| EX
is  ||| S:1235 E:1238 ||| VBZ
evidence  ||| S:1238 E:1247 ||| NN
that  ||| S:1247 E:1252 ||| IN
RAAS  ||| S:1252 E:1257 ||| NNP
inhibition  ||| S:1257 E:1268 ||| NN
is  ||| S:1268 E:1271 ||| VBZ
also  ||| S:1271 E:1276 ||| RB
useful  ||| S:1276 E:1283 ||| JJ
in  ||| S:1283 E:1286 ||| IN
cardiorenal  ||| S:1286 E:1298 ||| JJ
syndrome ||| S:1298 E:1306 ||| NN
.  ||| S:1306 E:1308 ||| .
However ||| S:1308 E:1315 ||| RB
,  ||| S:1315 E:1317 ||| ,
RAAS  ||| S:1317 E:1322 ||| NNP
inhibition ||| S:1322 E:1332 ||| NN
,  ||| S:1332 E:1334 ||| ,
while  ||| S:1334 E:1340 ||| IN
potentially  ||| S:1340 E:1352 ||| RB
useful  ||| S:1352 E:1359 ||| JJ
in  ||| S:1359 E:1362 ||| IN
the  ||| S:1362 E:1366 ||| DT
management  ||| S:1366 E:1377 ||| NN
of  ||| S:1377 E:1380 ||| IN
cardiorenal  ||| S:1380 E:1392 ||| JJ
syndrome ||| S:1392 E:1400 ||| NN
,  ||| S:1400 E:1402 ||| ,
is  ||| S:1402 E:1405 ||| VBZ
not  ||| S:1405 E:1409 ||| RB
the  ||| S:1409 E:1413 ||| DT
' ||| S:1413 E:1414 ||| POS
magic  ||| S:1414 E:1420 ||| JJ
bullet ||| S:1420 E:1426 ||| NN
' ||| S:1426 E:1427 ||| POS
,  ||| S:1427 E:1429 ||| ,
is  ||| S:1429 E:1432 ||| VBZ
sometimes  ||| S:1432 E:1442 ||| RB
limited  ||| S:1442 E:1450 ||| VBN
by  ||| S:1450 E:1453 ||| IN
adverse  ||| S:1453 E:1461 ||| JJ
renal  ||| S:1461 E:1467 ||| JJ
events ||| S:1467 E:1473 ||| NNS
,  ||| S:1473 E:1475 ||| ,
is  ||| S:1475 E:1478 ||| VBZ
not  ||| S:1478 E:1482 ||| RB
applicable  ||| S:1482 E:1493 ||| JJ
to  ||| S:1493 E:1496 ||| TO
all  ||| S:1496 E:1500 ||| DT
patients ||| S:1500 E:1508 ||| NNS
,  ||| S:1508 E:1510 ||| ,
and  ||| S:1510 E:1514 ||| CC
must  ||| S:1514 E:1519 ||| MD
be  ||| S:1519 E:1522 ||| VB
applied  ||| S:1522 E:1530 ||| VBN
by  ||| S:1530 E:1533 ||| IN
physicians  ||| S:1533 E:1544 ||| NNS
with  ||| S:1544 E:1549 ||| IN
due  ||| S:1549 E:1553 ||| JJ
diligence  ||| S:1553 E:1563 ||| NN
and  ||| S:1563 E:1567 ||| CC
caution ||| S:1567 E:1574 ||| NN
.  ||| S:1574 E:1576 ||| .
Nevertheless ||| S:1576 E:1588 ||| RB
,  ||| S:1588 E:1590 ||| ,
a  ||| S:1590 E:1592 ||| DT
more  ||| S:1592 E:1597 ||| RBR
comprehensive  ||| S:1597 E:1611 ||| JJ
multidisciplinary  ||| S:1611 E:1629 ||| JJ
multipronged  ||| S:1629 E:1642 ||| JJ
approach  ||| S:1642 E:1651 ||| NN
to  ||| S:1651 E:1654 ||| TO
managing  ||| S:1654 E:1663 ||| VBG
patients  ||| S:1663 E:1672 ||| NNS
with  ||| S:1672 E:1677 ||| IN
cardiorenal  ||| S:1677 E:1689 ||| JJ
syndrome  ||| S:1689 E:1698 ||| NN
is  ||| S:1698 E:1701 ||| VBZ
even  ||| S:1701 E:1706 ||| RB
more  ||| S:1706 E:1711 ||| RBR
pragmatic  ||| S:1711 E:1721 ||| JJ
and  ||| S:1721 E:1725 ||| CC
commonsense  ||| S:1725 E:1737 ||| VB
given  ||| S:1737 E:1743 ||| VBN
the  ||| S:1743 E:1747 ||| DT
multiple  ||| S:1747 E:1756 ||| JJ
mechanisms  ||| S:1756 E:1767 ||| NNS
and  ||| S:1767 E:1771 ||| CC
pathogenetic  ||| S:1771 E:1784 ||| NNS
pathways  ||| S:1784 E:1793 ||| VBP
implicated  ||| S:1793 E:1804 ||| VBN
in  ||| S:1804 E:1807 ||| IN
the  ||| S:1807 E:1811 ||| DT
causation  ||| S:1811 E:1821 ||| NN
and  ||| S:1821 E:1825 ||| CC
perpetuation  ||| S:1825 E:1838 ||| NN
of  ||| S:1838 E:1841 ||| IN
cardiorenal  ||| S:1841 E:1853 ||| JJ
syndrome ||| S:1853 E:1861 ||| NN
.  ||| S:1861 E:1863 ||| .
